Hyper-D

Hyper-D is a high-tech enterprise focused on innovative drug research and development. By integrating artificial intelligence technology with multidisciplinary fields such as computational chemistry, biochemistry, medicinal chemistry, pharmacology, bioinformatics, and clinical medicine, Hyper-D is committed to building intelligent R&D technologies for innovative drugs. This enhances the efficiency and success rate of key processes in drug discovery, design, evaluation, and synthesis, effectively shortening drug R&D time while reducing costs and risks. The core technical team mainly comes from the Institute of Materia Medica at Peking Union Medical College, the Academy of Military Medical Sciences, and top artificial intelligence research institutes, possessing strong capabilities in innovative drug R&D. Hyper-D has established the "PUMC-Hyper-D AI Joint Laboratory" with the Institute of Materia Medica and formed multiple collaborations with the Academy of Military Medical Sciences. Leveraging the Academy's strengths in biological evaluation, Hyper-D develops novel active compounds with core intellectual property rights.